论文部分内容阅读
此次国家医保药品准入谈判工作是《国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)》调整的有机组成部分。纵观全过程,从2017版医保目录公布,到拟谈判品种的公示,再到谈判协议达成,笔者认为国家医保药品准入首次谈判具有以下七个特点:以临床需求为基准,科学遴选谈判品种在2017版目录遴选过程中,通过对药品临床价值和需求进行反复专
The negotiation of national medical insurance access is an organic part of the adjustment of the “National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Catalog of Medicines (2017 version)”. Throughout the whole process, from the publication of the 2017 version of the Medicare Catalog to the publicity of the negotiated varieties and the negotiation of the agreement, the author believes that the first national negotiable drug access negotiations have the following seven characteristics: Based on the clinical needs, the scientific selection of the negotiated varieties In the 2017 version of the directory selection process, through the clinical value of drugs and needs repeated